NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Purple Biotech Ltd (TA: KTOV)

 
KTOV Technical Analysis
5
As on 20th Oct 2025 KTOV STOCK Price closed @ 1.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 12.13 & Strong Sell for SHORT-TERM with Stoploss of 21.17 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

KTOVSTOCK Price

Open 1.10 Change Price %
High 1.10 1 Day 0.00 0.00
Low 1.10 1 Week 0.10 10.00
Close 1.10 1 Month -2.70 -71.05
Volume 1196097 1 Year -24.10 -95.63
52 Week High 34.40 | 52 Week Low 1.00
 
TA Israel Most Active Stocks
TA125 2008.05 1.06%
ORL 88.60 -1.12%
BLRX 2.10 0.00%
MNRT 238.50 -0.17%
SCC 406.30 -6.60%
XTLB 4.50 -2.17%
POLI 6481.00 3.86%
ELAL 1332.00 -1.33%
MGDL 1072.00 2.58%
LUMI 6391.00 3.03%
 
TA Israel Top Gainers Stocks
TDGN-L 171.50 17.55%
MCRNT 372.50 16.84%
CNMD 45.10 10.54%
CNMD 45.10 10.54%
KRNV 3.20 10.34%
NXGN 52.40 8.94%
NXGN 52.40 8.94%
FNTS 224.80 8.60%
FNTS 224.80 8.60%
SFET 65.10 8.50%
 
TA Israel Top Losers Stocks
ELTR 11210.00 -94.87%
KMNK 51.00 -23.19%
ULTR 74.10 -16.74%
CNZN 150.00 -14.29%
BTX 520.00 -11.88%
BTX 520.00 -11.88%
BTX 520.00 -11.88%
BTX 520.00 -11.88%
BTX 520.00 -11.88%
ICB 1501.00 -11.45%
 
 
KTOV
Daily Charts
KTOV
Intraday Charts
Whats New @
Bazaartrend
KTOV
Free Analysis
 
KTOV Important Levels Intraday
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
RESISTANCE1.10
 
KTOV Forecast October 2025
4th UP Forecast39.06
3rd UP Forecast26.89
2nd UP Forecast19.36
1st UP Forecast11.84
1st DOWN Forecast-9.64
2nd DOWN Forecast-17.16
3rd DOWN Forecast-24.69
4th DOWN Forecast-36.86
 
KTOV Weekly Forecast
4th UP Forecast16.90
3rd UP Forecast11.83
2nd UP Forecast8.70
1st UP Forecast5.57
1st DOWN Forecast-3.37
2nd DOWN Forecast-6.50
3rd DOWN Forecast-9.63
4th DOWN Forecast-14.70
 
KTOV Forecast2025
4th UP Forecast70.09
3rd UP Forecast47.96
2nd UP Forecast34.29
1st UP Forecast20.61
1st DOWN Forecast-18.41
2nd DOWN Forecast-32.09
3rd DOWN Forecast-45.76
4th DOWN Forecast-67.89
 
 
KTOV Other Details
Segment EQ
Market Capital 227007808.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
KTOV Address
KTOV
 
KTOV Latest News
 
Your Comments and Response on Purple Biotech Ltd
 
KTOV Business Profile
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension in the United States, as well as in China and South Korea. Its oncology pipeline includes NT-219, a small molecule that is advancing as a monotherapy treatment of advanced solid tumors and in combination with cetuximab for the treatment of recurrent or metastatic squamous cell carcinoma of head and neck cancer in a planned phase 1/2 study; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD1 checkpoint inhibitors for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. is headquartered in Tel Aviv, Israel. Address: One Azrieli Center, Tel Aviv, Israel, 6701101
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service